Why is Amerise BioScie falling/rising?

As of 23-Sep, Amerise Biosciences Ltd is experiencing a decline in its stock price, currently at Rs. 0.66, which represents a decrease of 0.04 or 5.71%. The stock has hit a new 52-week low today and is underperforming its sector by 6.04%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Over the past week, the stock has declined by 5.71%, and year-to-date, it has fallen by 45.45%. Despite a notable increase in delivery volume, which rose by 121.49% against the 5-day average, the overall performance remains weak, with no positive factors reported to counterbalance the negative trends.
Broader Market Context: In comparison to the benchmark Sensex, which has seen a slight decline of 0.34% over the past week, Amerise Biosciences Ltd's performance is significantly worse. The stock's year-to-date performance of -45.45% starkly contrasts with the Sensex's gain of 5.07%, highlighting a substantial underperformance in the broader market context. This disparity suggests that while the market may be stabilizing or improving, Amerise Biosciences Ltd is struggling to maintain investor confidence, contributing to its ongoing price decline.